ArticleBulletin of the World Health Organization2019
Evidence needed for antimicrobial resistance surveillance systems.
Article in Bulletin of the World Health Organization, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of surveillance systems for AMR in Africa.The Journal of antimicrobial chemotherapy · 2022Pooled it
- A comparison of antibiotic resistance reports in pharmacovigilance databases and conventional surveillance across "One Health".Frontiers in public health · 2026Article
- Antimicrobial Resistance in European Companion Animals Practice: A One Health Approach.Animals : an open access journal from MDPI · 2025Review
- Systematic review on evaluation tools applicable to One Health surveillance systems: A call for adapted methodology.One health (Amsterdam, Netherlands) · 2025Review
- Building capacities in Sub-Saharan African countries for antimicrobial resistance surveillance in the food and agriculture sectors using the FAO ATLASS tool.Frontiers in veterinary science · 2025Article
- Integrated surveillance systems for antibiotic resistance in a One Health context: a scoping review.BMC public health · 2024Article
- Explaining the barriers faced by veterinarians against preventing antimicrobial resistance: an innovative interdisciplinary qualitative study.BMC infectious diseases · 2024Article
- Prevalence of Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2024Article
- A participatory approach to move towards a One Health surveillance system for anthrax in Burkina Faso.PloS one · 2024Article
- Strengthening antimicrobial resistance surveillance systems: a scoping review.BMC infectious diseases · 2023Article
- Evaluating the OH-EpiCap tool using the Danish integrated surveillance program for AMU and AMR as a case study.Frontiers in public health · 2023Article
- Capturing systematically users' experience of evaluation tools for integrated AMU and AMR surveillance.Frontiers in veterinary science · 2023Article
- Users' perception of the OH-EpiCap evaluation tool based on its application to nine national antimicrobial resistance surveillance systems.Frontiers in public health · 2023Article
- State of Knowledge on the Acquisition, Diversity, Interspecies Attribution and Spread of Antimicrobial Resistance between Humans, Animals and the Environment: A Systematic Review.Antibiotics (Basel, Switzerland) · 2022Review
- Human microbiota drives hospital-associated antimicrobial resistance dissemination in the urban environment and mirrors patient case rates.Microbiome · 2022Article
- Perception of poultry veterinarians on the use of antimicrobials and antimicrobial resistance in egg production.Poultry science · 2022Article
- A systematic approach toward progressive improvement of national antimicrobial resistance surveillance systems in food and agriculture sectors.Frontiers in veterinary science · 2022Article
- An integrated surveillance network for antimicrobial resistance, India.Bulletin of the World Health Organization · 2021Article
- Evaluating the Integration of One Health in Surveillance Systems for Antimicrobial Use and Resistance: A Conceptual Framework.Frontiers in veterinary science · 2021Article
- Evaluating Integrated Surveillance for Antimicrobial Use and Resistance in England: A Qualitative Study.Frontiers in veterinary science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One Health surveillance for antimicrobial resistance has been promoted by the scientific community and by international organizations for more than a decade. In this article, we highlight issues that need to be addressed to improve the understanding of the effectiveness of One Health surveillance for antimicrobial resistance. We also outline the evidence needed to support countries planning to increase the level of integration of their surveillance system. Based on experience in Canada and other countries, we argue that more effort is needed to understand and measure the added value of One Health for antimicrobial resistance surveillance and to identify the most effective integration strategies. To date, guidelines for the development of One Health surveillance have focused mainly on the types of data that should be integrated. However, it may be necessary to apply the concept of One Health to surveillance tasks beyond data integration to realize the full value of the approach. Integration can be enhanced across different surveillance activities (data collection, analysis, interpretation and dissemination), taking account of the different skills and perspectives of experts and stakeholders involved. More research is needed to investigate the mechanisms through which a One Health approach to surveillance can increase the performance of antimicrobial resistance surveillance and, ultimately, improve health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.